Featured Insights
September 22, 2026
Article
The consultation may impact how UK companies report on sustainability matters.
September 21, 2026
Client Alert
Dompé’s $32 million settlement with DOJ (following a voluntary self-disclosure) offers important lessons to pharmaceutical manufactures and underscores the government’s heightened focus on manufacturer relationships with patient assistance foundations.
September 21, 2026
Podcast
CMS proposed the RAPID pathway to fast-track Medicare coverage for breakthrough medical devices. The Latham team explores how the pathway works and what it means for device manufacturers.